Rehn, MariusChew, Michelle S.Kalliomaki, MaijaOlkkola, Klaus T.Sigurðsson, Martin IngiMøller, Morten Hylander2025-11-202025-11-202024-10Rehn, M, Chew, M S, Kalliomaki, M, Olkkola, K T, Sigurðsson, M I & Møller, M H 2024, 'ESAIC focused guideline for the use of cardiac biomarkers in perioperative risk evaluation : Endorsement by the Scandinavian Society of Anaesthesiology and Intensive Care Medicine', Acta anaesthesiologica Scandinavica, vol. 68, no. 9, pp. 1179-1181. https://doi.org/10.1111/aas.144720001-5172227146850000c7dbb-639f-43dd-8378-6a24071d7afa85195499679https://hdl.handle.net/20.500.11815/7566Publisher Copyright: © 2024 The Author(s). Acta Anaesthesiologica Scandinavica published by John Wiley & Sons Ltd on behalf of Acta Anaesthesiologica Scandinavica Foundation.Background: The Clinical Practice Committee of the Scandinavian Society of Anaesthesiology and Intensive Care Medicine endorses the clinical practice guideline “ESAIC focused guideline for the use of cardiac biomarkers in perioperative risk evaluation.” The guideline can provide guidance to Nordic anaesthesiologists on the perioperative use of cardiac biomarkers in patients undergoing non-cardiac surgery.33582931179-1181eninfo:eu-repo/semantics/openAccessAGREE IIbiomarkerscardiologyclinical practice guidelineperioperative carerisk stratificationSSAIAnesthesiology and Pain MedicineESAIC focused guideline for the use of cardiac biomarkers in perioperative risk evaluation : Endorsement by the Scandinavian Society of Anaesthesiology and Intensive Care Medicine/dk/atira/pure/researchoutput/researchoutputtypes/contributiontojournal/systematicreview10.1111/aas.14472